Sage Therapeutics, Inc. (SAGE)
NASDAQ: SAGE · Real-Time Price · USD
6.94
-0.14 (-1.98%)
Jan 21, 2025, 4:00 PM EST - Market closed
Sage Therapeutics Employees
Sage Therapeutics had 487 employees as of December 31, 2023. The number of employees decreased by 202 or -29.32% compared to the previous year.
Employees
487
Change (1Y)
-202
Growth (1Y)
-29.32%
Revenue / Employee
$218,478
Profits / Employee
-$693,211
Market Cap
424.54M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
SAGE News
- 7 days ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sage Therapeutics, Inc. (SAGE) And Encourages Shareholders to Reach Out - Accesswire
- 8 days ago - Sage Therapeutics Stock Soars as Biogen Makes Unsolicited Takeover Bid - Investopedia
- 8 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sage Therapeutics, Inc. (SAGE) and Encourages Shareholders to Learn More About the Investigation - Accesswire
- 8 days ago - Why Is Depression-Focused Sage Therapeutics Stock Surging Higher On Monday? - Benzinga
- 8 days ago - Sage Therapeutics Stock Rockets 35% Higher After Takeover Bid From Biogen - Barrons
- 9 days ago - Sage Therapeutics to Present 2025 Strategic Focus at 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
- 9 days ago - Sage Therapeutics, Inc. (SAGE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire
- 11 days ago - Sage Therapeutics Confirms Receipt of Unsolicited Nonbinding Acquisition Proposal from Biogen - Business Wire